Cause of Death
"Cause of Death" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint.
Descriptor ID |
D002423
|
MeSH Number(s) |
E05.318.308.985.550.250 L01.280.975.550.250 N01.224.935.698.100 N06.850.505.400.975.550.250 N06.850.520.308.985.550.250
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cause of Death".
Below are MeSH descriptors whose meaning is more specific than "Cause of Death".
This graph shows the total number of publications written about "Cause of Death" by people in this website by year, and whether "Cause of Death" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 1 | 1 | 2 | 2007 | 0 | 1 | 1 | 2008 | 1 | 2 | 3 | 2009 | 0 | 1 | 1 | 2010 | 1 | 0 | 1 | 2012 | 0 | 1 | 1 | 2015 | 0 | 1 | 1 | 2016 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cause of Death" by people in Profiles.
-
Nauman J, Nes BM, Lavie CJ, Jackson AS, Sui X, Coombes JS, Blair SN, Wisløff U. Prediction of Cardiovascular Mortality by Estimated Cardiorespiratory Fitness Independent of Traditional Risk Factors: The HUNT Study. Mayo Clin Proc. 2017 Feb; 92(2):218-227.
-
D'Amico AV, Chen MH, Renshaw A, Loffredo M, Kantoff PW. Long-term Follow-up of a Randomized Trial of Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer. JAMA. 2015 Sep 22-29; 314(12):1291-3.
-
Kim SP, Thompson RH, Boorjian SA, Weight CJ, Han LC, Murad MH, Shippee ND, Erwin PJ, Costello BA, Chow GK, Leibovich BC. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol. 2012 Jul; 188(1):51-7.
-
Papa L, Akinyi L, Liu MC, Pineda JA, Tepas JJ, Oli MW, Zheng W, Robinson G, Robicsek SA, Gabrielli A, Heaton SC, Hannay HJ, Demery JA, Brophy GM, Layon J, Robertson CS, Hayes RL, Wang KK. Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury. Crit Care Med. 2010 Jan; 38(1):138-44.
-
D'Amico AV, Chen MH, Renshaw AA, Loffredo M, Kantoff PW. Interval to testosterone recovery after hormonal therapy for prostate cancer and risk of death. Int J Radiat Oncol Biol Phys. 2009 Sep 01; 75(1):10-5.
-
D'Amico AV, Chen MH, Renshaw AA, Loffredo M, Kantoff PW. Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer. Cancer. 2008 Dec 15; 113(12):3290-7.
-
Ostrom MP, Gopal A, Ahmadi N, Nasir K, Yang E, Kakadiaris I, Flores F, Mao SS, Budoff MJ. Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography. J Am Coll Cardiol. 2008 Oct 14; 52(16):1335-43.
-
D'Amico AV, Chen MH, Renshaw AA, Loffredo M, Kantoff PW. Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial. JAMA. 2008 Jan 23; 299(3):289-95.
-
Nguyen PL, Chen MH, Renshaw AA, Sussman B, D'Amico AV. Effect of definition of preradiotherapy prostate-specific antigen velocity on its association with prostate cancer-specific mortality and all-cause mortality. Urology. 2007 Aug; 70(2):288-93.
-
D'Amico AV, Cote K, Loffredo M, Renshaw AA, Schultz D. Determinants of prostate cancer specific survival following radiation therapy during the prostate specific antigen era. J Urol. 2003 Dec; 170(6 Pt 2):S42-6; discussion S46-7.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|